Multiple complications and withdrawal syndrome associated with quetiapine/venlafaxine intoxication

被引:15
|
作者
Précourt, A
Dunewicz, M
Grégoire, G
Williamson, DR
机构
[1] Hop St Justine, Dept Pharm Serv, Montreal, PQ H3T 1C5, Canada
[2] Hop Sacre Coeur Montreal, Dept Emergency Med, Montreal, PQ H3T 1C5, Canada
[3] Hop Sacre Coeur, Dept Intens Care Med, Montreal, PQ, Canada
[4] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada
[5] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada
关键词
neuroleptic malignant syndrome; quetiapine; venlafaxine;
D O I
10.1345/aph.1E073
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To report a case of quetiapine/venlafaxine intoxication associated with multiple complications and to review their possible relationship with these 2 drugs. Case Summary: A 53-year-old white man was admitted to the hospital for loss of consciousness secondary to voluntary intoxication with venlafaxine and quetiapine. Several complications were attributable to this intoxication including seizures, prolonged coma, respiratory depression, neuroleptic malignant syndrome, prolonged QRS and QTc intervals, and a possible venlafaxine withdrawal syndrome. Discussion: Quetiapine could be responsible for the neuroleptic malignant syndrome presented in this case. Moreover, venlafaxine intoxication, fever, autonomic instability, and myoclonus presented serotonin syndrome as a differential diagnosis. Potential causes of seizures and prolongation of the QRS and QTc intervals are reviewed. Finally, prolonged coma and late venlafaxine withdrawal are discussed with regard to the pharmacodynamics and pharmacokinetics of drug elimination in the context of intoxication. Conclusions: Clinicians should be aware of possible complications following intoxication with atypical antipsychotics and antidepressants, including protracted altered mental status.
引用
收藏
页码:153 / 156
页数:4
相关论文
共 50 条
  • [1] Restless Legs Syndrome Associated With the Combined Use of Quetiapine and Venlafaxine
    Michopoulos, Ioannis
    Ferentinos, Panagiotis
    Oulis, Panagiotis
    Gournellis, Rossetos
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (01) : 159 - 161
  • [2] VENLAFAXINE WITHDRAWAL SYNDROME
    Sabljic, Vladimir
    Ruzic, Klementina
    Rakun, Radmir
    PSYCHIATRIA DANUBINA, 2011, 23 (01) : 117 - 119
  • [3] Venlafaxine withdrawal syndrome
    Macbeth, R
    Rajagopalan, M
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1998, 28 (02): : 218 - 218
  • [4] Neuroleptic Malignant Syndrome with Low-dose Quetiapine After Venlafaxine Withdrawal: A Case Report
    Ozden, Hayri Can
    Gurel, Seref Can
    TURK PSIKIYATRI DERGISI, 2024,
  • [5] Possible venlafaxine withdrawal syndrome
    Farah, A
    Lauer, TE
    AMERICAN JOURNAL OF PSYCHIATRY, 1996, 153 (04): : 576 - 576
  • [6] Neonatal Withdrawal Syndrome Associated with Fluoxetine and Venlafaxine Use in Pregnancy
    Law, R.
    Campbell, S.
    Bayliff, C.
    CANADIAN JOURNAL OF HOSPITAL PHARMACY, 2005, 58 : 54 - 55
  • [7] Neuroleptic malignant syndrome associated with quetiapine and venlafaxine use: a case report and discussion
    Woods, Gary
    Taggart, Catherine
    Boggs, Robert
    Cadden, Ian
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2013, 3 (01) : 53 - 55
  • [8] Withdrawal reaction associated with venlafaxine
    Johnson, H
    Bouman, WP
    Lawton, J
    BRITISH MEDICAL JOURNAL, 1998, 317 (7161): : 787 - 787
  • [9] Withdrawal reactions associated with venlafaxine
    Parker, G
    Blennerhassett, J
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 1998, 32 (02): : 291 - 294
  • [10] Withdrawal syndrome after discontinuation of venlafaxine
    Agelink, MW
    Zitzelsberger, A
    Klieser, E
    AMERICAN JOURNAL OF PSYCHIATRY, 1997, 154 (10): : 1473 - 1474